Q2 2020 TG Therapeutics Inc Earnings Call Transcript
Hello, and welcome to the TG Therapeutics Second Quarter 2020 Earnings Conference Call. (Operator Instructions) As a reminder, this conference is being recorded.
It's now my pleasure to turn the call over to Jenna Bosco, Senior Vice President, Corporate Communications. Please go ahead.
Thank you. Good morning, and welcome to our conference call to discuss TG Therapeutics' second quarter 2020 financial results and business update. I'm Jenna Bosco, TG's Senior Vice President of Corporate Communications, and I welcome you to our conference call today.
Following our safe harbor statement, Sean Power, TG's Chief Financial Officer, will provide a brief overview of our financial results and then turn the call over to Michael Weiss, the company's Executive Chairman and Chief Executive Officer, who will provide an overview of the ongoing development of our lead compounds, ublituximab and umbralisib, as well as an update on our overall company standing.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |